Peroxisome proliferators-activated alpha agonist treatment ameliorates hepatic damage in rats with obstructive jaundice: an experimental study
Open Access
- 28 November 2007
- journal article
- Published by Springer Nature in BMC Gastroenterology
- Vol. 7 (1) , 44
Abstract
Background: Peroxisome proliferators-activated receptor alpha (PPARα) activation modulates cholesterol metabolism and suppresses bile acid synthesis. This study aims to evaluate the effect of short-term administration of fenofibrate, a PPARα agonist, on proinflammatory cytokines, apoptosis, and hepatocellular damage in cholestasis. Methods: Forty male Wistar rats were randomly divided into four groups: I = sham operated, II = bile duct ligation (BDL), III = BDL + vehicle (gum Arabic), IV = BDL + fenofibrate (100 mg/kg/day). All rats were sacrificed on 7th day after obtaining blood samples and liver tissue. Total bilirubin, aminotransferase (AST), alanine aminotransferase (ALT) and alkaline phosphatase (ALP), gamma-glutamyl transferase, (GGT), tumor necrosis factor alpha (TNF-α), interleukin 1 beta (IL-1 β), and total bile acid (TBA) in serum, and liver damage scores; portal inflammation, necrosis, bile duct number, in liver tissue were evaluated. Apoptosis in liver was also assessed by immunohistochemical staining. Results: Fenofibrate administration significantly reduced serum total bilirubin, AST, ALT, ALP, and GGT, TNF-α, IL-1 β levels, and TBA (P < 0.01). Hepatic portal inflammation, hepatic necrosis, number of the bile ducts and apoptosis in rats with BDL were more prominent than the sham-operated animals (P < 0.01). PPARα induction improved all histopathologic parameters (P < 0.01), except for the number of the bile duct, which was markedly increased by fenofibrate therapy (P < 0.01). Conclusion: Short-term administration of fenofibrate to the BDL rats exerts beneficial effects on hepatocellular damage and apoptosis.Keywords
This publication has 31 references indexed in Scilit:
- Activation of Peroxisome Proliferator–Activated Receptor Alpha Enhances Apoptosis in the Mouse LiverToxicological Sciences, 2006
- Effects of peroxisome proliferator-activated receptor α activation on pathways contributing to cholesterol homeostasis in rat hepatocytesBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2004
- The peroxisome proliferator-activated receptor α (PPARα): role in hepatocarcinogenesisMolecular and Cellular Endocrinology, 2002
- Suppression of mouse hepatocyte apoptosis by peroxisome proliferators: role of PPARα and TNFαMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2000
- The non-genotoxic hepatocarcinogen nafenopin suppresses rodent hepatocyte apoptosis induced by TGFbeta1, DNA damage and FasCarcinogenesis, 1998
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995
- Influence of bezafibrate on hepatic cholesterol metabolism in gallstone patients: Reduced activity of cholesterol 7α-hydroxylaseHepatology, 1995
- Effects of Gemfibrozil and Other Fibric Acid Derivatives on Blood Lipids and LipoproteinsThe Journal of Clinical Pharmacology, 1991
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987
- Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis†Hepatology, 1981